{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:02:39Z","timestamp":1771945359273,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272400"],"award-info":[{"award-number":["82272400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2406600"],"award-info":[{"award-number":["2022YFC2406600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2406604"],"award-info":[{"award-number":["2022YFC2406604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.medcli.2025.107273","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:16:52Z","timestamp":1767781012000},"page":"107273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The distribution and clinical significance of anti-nuclear antibodies in patients with idiopathic inflammatory myopathy in Southwest China"],"prefix":"10.1016","volume":"166","author":[{"given":"Yixue","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liye","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qibing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuochun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.107273_bib0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.medcli.2025.107273_bib0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12016-020-08814-5","article-title":"Predictive features and clinical presentation of interstitial lung disease in inflammatory myositis","volume":"60","author":"Vojinovic","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.medcli.2025.107273_bib0160","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2025.107273_bib0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","article-title":"Toward new classification criteria for juvenile idiopathic arthritis: first steps pediatric rheumatology international trials organization international consensus","volume":"46","author":"Martini","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2025.107273_bib0175","article-title":"Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases","volume":"5","author":"Andrade","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.medcli.2025.107273_bib0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.autrev.2007.08.003","article-title":"A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders","volume":"7","author":"Stinton","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2025.107273_bib0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s40001-022-00809-6","article-title":"High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection","volume":"27","author":"de Castro","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.medcli.2025.107273_bib0190","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0195","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.medcli.2025.107273_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103437","article-title":"Characterizing local antibody responses in the muscle of inclusion body myositis patients","volume":"154","author":"Jayaraman","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1016\/j.medcli.2025.107273_bib0205","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","volume":"83","author":"Pinal-Fernandez","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0210","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/key451","article-title":"Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis","volume":"58","author":"Infantino","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.107273_bib0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1462242","article-title":"Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease","volume":"15","author":"Burbelo","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2025.107273_bib0220","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0225","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.medcli.2025.107273_bib0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13075-020-02403-9","article-title":"Association study between immune-related miRNAs and mixed connective tissue disease","volume":"23","author":"Stypinska","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.medcli.2025.107273_bib0235","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.24631","article-title":"Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease","volume":"60","author":"Richards","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2025.107273_bib0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.850759","article-title":"Anti-nuclear antibodies patterns in patients with systemic lupus erythematosus and their correlation with other diagnostic immunological parameters","volume":"13","author":"Al-Mughales","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2025.107273_bib0245","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23546","article-title":"Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases","volume":"34","author":"Wei","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.medcli.2025.107273_bib0250","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003608","article-title":"Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register","volume":"3","author":"Frodlund","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.medcli.2025.107273_bib0255","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/rheumatology\/kes261","article-title":"Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese","volume":"52","author":"Li","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.107273_bib0260","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1097\/RHU.0000000000001350","article-title":"Myositis-specific antibodies and myositis-associated antibodies in patients with idiopathic inflammatory myopathies from the PANLAR myositis study group","volume":"27","author":"Gonzalez-Bello","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.medcli.2025.107273_bib0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard-2022-222935","article-title":"Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies","volume":"82","author":"Zhou","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0270","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1136\/annrheumdis-2018-213153","article-title":"Detection of myositis-specific antibodies: additional notes","volume":"78","author":"Mahler","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0275","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20975907","article-title":"The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study","volume":"12","author":"Lackner","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.medcli.2025.107273_bib0280","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1093\/rheumatology\/keac039","article-title":"Concordance between myositis autoantibodies and anti-nuclear antibody patterns in a real-world, Australian cohort","volume":"61","author":"He","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.107273_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.medcli.2025.107273_bib0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13075-024-03382-x","article-title":"Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy","volume":"26","author":"Weng","year":"2024","journal-title":"Arthritis Res Ther"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325005019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325005019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:08:50Z","timestamp":1771942130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325005019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0025775325005019"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107273","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The distribution and clinical significance of anti-nuclear antibodies in patients with idiopathic inflammatory myopathy in Southwest China","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107273"}}